Open Label study to evaluate the safety and Pharmacokinetics of PF-06412528 in children 7-17 for treatment of moderate to severe pain
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Pfizer, Inc.
Start Date
February 21, 2018
End Date
November 5, 2019
Administered By
Medicine, Hematology
Awarded By
Pfizer, Inc.
Start Date
February 21, 2018
End Date
November 5, 2019